Lavipharm (ATH:LAVI) Accounts Payable & Accrued Expense : €26.07 Mil (As of Jun. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Lavipharm Accounts Payable & Accrued Expense?

Lavipharm's quarterly accounts payable & accrued expense increased from Jun. 2023 (€22.35 Mil) to Dec. 2023 (€23.55 Mil) and increased from Dec. 2023 (€23.55 Mil) to Jun. 2024 (€26.07 Mil).

Lavipharm's annual accounts payable & accrued expense increased from Dec. 2021 (€16.36 Mil) to Dec. 2022 (€20.59 Mil) and increased from Dec. 2022 (€20.59 Mil) to Dec. 2023 (€23.55 Mil).

Lavipharm Accounts Payable & Accrued Expense Historical Data

The historical data trend for Lavipharm's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lavipharm Accounts Payable & Accrued Expense Chart

Lavipharm Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

12.33

11.77

16.36

20.59

23.55

Lavipharm Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial						19.09	20.59	22.35	23.55	26.07

Lavipharm Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Lavipharm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lavipharm SA (ATH:LAVI) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

BXA0:Germany

Address

Agias Marinas Street, PO Box 59, Peania Attica, GRC, 19002

Website

http://www.lavipharm.com

Lavipharm SA develops, manufactures, markets and distributes pharmaceutical, cosmetic and consumer health products in Greece and internationally. The company's product portfolio includes safe and effective therapeutic solutions that meet consumer' needs for health and wellbeing. Its main product categories are Cardiology, Oncology, Urology, Neurology, Psychiatry, General Medicine, Self- Treatment and Dermocosmetic care.

Lavipharm Headlines

No Headlines